1492 Capital Management’s Pacira BioSciences PCRX Stock Holding History

1492 Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$2.44M	Sell
2023 Q2	$3.88M	Buy
2023 Q1	$3.73M	Buy
2022 Q4	$624K	Hold
2022 Q3	$859K	Sell
2022 Q2	$942K	Buy
2022 Q1	$962K	Buy